The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

California-based Freenome, a cancer detection company, announced a strategic collaboration agreement with pharma giant Roche with the aim of commercializing Freenome's cancer screening technology ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Freenome, a privately held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection with a routine blood ...

If liquid biopsies haven’t yet arrived, they’re definitely preparing the cabin for a timely descent. On Wednesday, San Francisco, California-based Freenome announced a $65 million Series A funding ...

Verily, part of Google's parent company Alphabet, quietly invested in a life sciences start-up called Freenome and built it a lab to sweeten the deal. That company has now moved in to the lab on ...

From a routine blood draw, Freenome’s diagnostics technology finds biological and genetic signs of cancer before they can be detected by currently available testing methods. A pivotal clinical trial ...

Freenome on Tuesday announced the launch of its new Sanderson Study, which will use its multiomics platform, in combination with real-world data, some derived from Oracle Cerner's Learning Health ...

One of the major problems that technology companies working to find a cure for cancer need to solve is finding a safe, minimally invasive way to detect cancers early. Almost all cancer screening will ...

Freenome, a Silicon Valley startup aiming to develop blood tests to detect cancer early, is choosing its first product: a test to detect colon cancer. The company was founded by Chief Executive ...